NCT05435209View on ClinicalTrials.gov

Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
HPV InfectionHPV Vaccination
Interventions
DRUG

Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine

Gardasil

Trial Locations (1)

Unknown

Phrd-Ccr-Kemri, Thika

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Washington

OTHER